Nifty 17110.15 (-0.97%)
Sensex 57276.94 (-1.00%)
Nifty Bank 37982.1 (0.73%)
Nifty IT 33475.05 (-3.55%)
Nifty Financial Services 17763.15 (-0.15%)
Adani Ports 709.10 (-0.28%)
Asian Paints 3116.95 (-0.96%)
Axis Bank 773.85 (2.88%)
B P C L 382.20 (-0.09%)
Bajaj Auto 3501.10 (0.92%)
Bajaj Finance 6837.00 (-1.82%)
Bajaj Finserv 15359.85 (-1.09%)
Bharti Airtel 707.25 (-0.65%)
Britannia Inds. 3494.15 (-1.28%)
Cipla 927.60 (2.42%)
Coal India 160.55 (-0.37%)
Divis Lab. 3939.85 (-2.70%)
Dr Reddys Labs 4256.35 (-3.33%)
Eicher Motors 2643.85 (-1.79%)
Grasim Inds 1687.05 (-1.99%)
H D F C 2503.35 (-1.08%)
HCL Technologies 1077.75 (-4.09%)
HDFC Bank 1474.95 (-0.88%)
HDFC Life Insur. 621.50 (-1.47%)
Hero Motocorp 2715.00 (-2.41%)
Hind. Unilever 2295.35 (-1.37%)
Hindalco Inds. 489.15 (0.70%)
I O C L 122.70 (1.03%)
ICICI Bank 794.65 (-0.87%)
IndusInd Bank 888.10 (0.44%)
Infosys 1678.60 (-2.53%)
ITC 214.60 (0.14%)
JSW Steel 626.10 (-0.80%)
Kotak Mah. Bank 1889.25 (1.87%)
Larsen & Toubro 1910.85 (-0.75%)
M & M 858.05 (0.42%)
Maruti Suzuki 8820.20 (2.53%)
Nestle India 18385.45 (-2.16%)
NTPC 135.00 (-0.22%)
O N G C 165.70 (0.33%)
Power Grid Corpn 214.85 (-1.83%)
Reliance Industr 2338.10 (-1.48%)
SBI Life Insuran 1211.65 (-1.33%)
Shree Cement 23961.80 (-2.19%)
St Bk of India 528.95 (2.78%)
Sun Pharma.Inds. 812.10 (0.50%)
Tata Consumer 705.95 (-0.25%)
Tata Motors 494.40 (0.78%)
Tata Steel 1088.35 (-1.87%)
TCS 3649.25 (-3.20%)
Tech Mahindra 1445.60 (-3.67%)
Titan Company 2310.05 (-2.80%)
UltraTech Cem. 7100.70 (0.03%)
UPL 771.95 (-2.43%)
Wipro 544.75 (-3.19%)

Eight years on, Emcure Pharma takes a second shot at IPO

19/08/2021

Pune-based Emcure Pharmaceuticals Ltd is making its second attempt to float an initial public offering (IPO), joining a bunch of healthcare companies to tap into the stock market buoyancy. 

Emcure has filed a draft prospectus with the capital markets regulator Securities and Exchange Board of India for the IPO that includes both primary and secondary share sales.

While the drugmaker aims to raise Rs 1,100 crore by issuing fresh shares in the IPO, its promoters and investor Bain Capital plan to sell a total of 18.16 million shares. Private equity firm Bain alone will sell almost 10 million shares.
Emcure joins a growing list of healthcare services and pharmaceutical companies to float an IPO. Already, companies such as pathology chain Krsnaa Diagnostics Ltd, hospital operator Krishna Institute of Medical Sciences and drugmakers Windlas Biotech Ltd and Glenmark Life Sciences Ltd have gone public this year.

Emcure’s planned IPO comes eight years after Emcure first approached SEBI for its maiden share sale in July 2013. However, the drugmaker eventually scrapped the proposal. 
Emcure makes and sells a wide range of pharmaceutical products across several therapeutic areas. The company claims it is the 12th largest drugmaker in India by revenue and the largest in segments such as gynaecologyand HIV anti virals .The company says it is also developing a Covid-19 vaccine.

Emcure was set up in 1981. It operates 14 manufacturing plants.The company’s consolidated net profit soared to Rs 418.59 crore for the year through March 2021 from Rs 100.61 crore a year earlier. Revenue from operations jumped to Rs 6,056.41 crore from Rs 5,048.55 crore.

Open Demat Account

Enter Mobile Number
Enter correct otp
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
SENSEX
57,276.94
-581.21 (-1.00%)
Nifty 50
17,110.15
-167.80 (-0.97%)
Nifty Bank
37,982.10
275.35 (0.73%)
Next Article

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number

Stocks Directory

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All 0-9